The Lone Biotech Bear?

Judging from the atmosphere at last week’s JP Morgan Healthcare conference in San Francisco – which industry veteran and long-time participant Henri Termeer described as the “most optimistic” he had every experienced – the industry’s well-documented problems are clearly behind us. After a decade in the doldrums, the biotech market is on a bull run stretching back more than a […]